Although vaccination is generally considered safe in the healthy population, existing guidelines for both pediatric and adult rheumatic diseases recommend to withhold live-attenuated vaccines in patients using IL-1 or IL-6 blocking agents, because of lack of safety data and the (theoretical) risk of introducing infection in an immune suppressed host [3–5]. Here, IL6 is linked to infection.